Literature DB >> 26088882

Effect of epileptic seizures on the cerebrospinal fluid--A systematic retrospective analysis.

Hayrettin Tumani1, Catherine Jobs2, Johannes Brettschneider3, Anselm C Hoppner4, Frank Kerling5, Susanne Fauser6.   

Abstract

OBJECTIVE: Analyses of the cerebrospinal fluid (CSF) are obligatory when epileptic seizures manifest for the first time in order to exclude life-threatening causes or treatable diseases such as acute infections or autoimmune encephalitis. However, there are only few systematic investigations on the effect of seizures themselves on CSF parameters and the significance of these parameters in differential diagnosis.
METHODS: CSF samples of 309 patients with epileptic and 10 with psychogenic seizures were retrospectively analyzed. CSF samples were collected between 1999 and 2008. Cell counts, the albumin quotient, lactate and Tau-protein levels were determined. Findings were correlated with seizure types, seizure etiology (symptomatic, cryptogenic, occasional seizure), and seizure duration.
RESULTS: Pathological findings were only observed in patients with epileptic but not with psychogenic seizures. The lactate concentration was elevated in 14%, the albumin quotient in 34%, and the Tau protein level in 36% of CSF samples. Cell counts were only slightly elevated in 6% of patients. Different seizure types influenced all parameters except for the cell count: In status epilepticus highest, in simple partial seizures lowest values were seen. Symptomatic partial and generalized epileptic seizures had significantly higher Tau-protein levels than cryptogenic partial seizures. In patients with repetitive and occasional epileptic seizures, higher Tau-protein levels were seen than in those with psychogenic seizures. Duration of epileptic seizures was positively correlated with the albumin quotient, lactate and Tau-protein levels. High variability of investigated CSF parameters within each subgroup rendered a clear separation between epileptic and psychogenic seizures impossible. SIGNIFICANCE: Elevated cell counts are infrequently observed in patients with epileptic seizures and should therefore not uncritically be interpreted as a postictal phenomenon. However, blood-CSF barrier disruption, increased glucose metabolism and elevation of neuronal damage markers are observed in considerable percentages of patients and depend on many factors such as etiology, seizure type and duration.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood–CSF barrier; Cerebrospinal fluid; Epilepsy; neuronal damage

Mesh:

Substances:

Year:  2015        PMID: 26088882     DOI: 10.1016/j.eplepsyres.2015.04.004

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

1.  L-lactate in cerebrospinal fluid can be used as a biomarker of encephalitis in cattle.

Authors:  Juliana M Curti; Gustavo R Queiroz; Priscilla F V Pereira; Mayara C Anjos; Karina K M C Flaiban; Júlio A N Lisbôa
Journal:  Can J Vet Res       Date:  2020-04       Impact factor: 1.310

2.  Insights into the development of pentylenetetrazole-induced epileptic seizures from dynamic metabolomic changes.

Authors:  Xue Zhao; Peixuan Cheng; Ru Xu; Kaili Meng; Sha Liao; Pu Jia; Xiaohui Zheng; Chaoni Xiao
Journal:  Metab Brain Dis       Date:  2022-07-15       Impact factor: 3.655

3.  Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.

Authors:  Sarah Gourmaud; Haochang Shou; David J Irwin; Kimberly Sansalone; Leah M Jacobs; Timothy H Lucas; Eric D Marsh; Kathryn A Davis; Frances E Jensen; Delia M Talos
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

4.  Cerebrospinal fluid lactate concentrations in dogs with seizure disorders.

Authors:  Christopher L Mariani; Carolyn J Nye; Laura Ruterbories; Debra A Tokarz; Lauren Green; Jeanie Lau; Natalia Zidan; Peter J Early; Karen R Muñana; Natasha J Olby; Chun-Sheng Lee; Julien Guevar
Journal:  J Vet Intern Med       Date:  2020-11-02       Impact factor: 3.333

Review 5.  Advances regarding Neuroinflammation Biomarkers with Noninvasive Techniques in Epilepsy.

Authors:  Hongrui Ma; Hua Lin
Journal:  Behav Neurol       Date:  2021-12-22       Impact factor: 3.342

6.  Revealing the Antiepileptic Effect of α-Asaronol on Pentylenetetrazole-Induced Seizure Rats Using NMR-Based Metabolomics.

Authors:  Xue Zhao; Lihong Liang; Ru Xu; Peixuan Cheng; Pu Jia; Yajun Bai; Yajun Zhang; Xinfeng Zhao; Xiaohui Zheng; Chaoni Xiao
Journal:  ACS Omega       Date:  2022-02-09

Review 7.  Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms.

Authors:  Kaylin Hwang; Rahil N Vaknalli; Kwaku Addo-Osafo; Mariane Vicente; Keith Vossel
Journal:  Front Aging Neurosci       Date:  2022-07-18       Impact factor: 5.702

8.  Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study.

Authors:  Anne Ahrens Østergaard; Thomas Vognbjerg Sydenham; Mads Nybo; Åse Bengård Andersen
Journal:  BMC Clin Pathol       Date:  2017-08-24

Review 9.  The Interconnected Mechanisms of Oxidative Stress and Neuroinflammation in Epilepsy.

Authors:  Anna L M Parsons; Eboni M V Bucknor; Enrico Castroflorio; Tânia R Soares; Peter L Oliver; Daniel Rial
Journal:  Antioxidants (Basel)       Date:  2022-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.